IBC-Ab002

· Immunobrain Checkpoint

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IBC-Ab002, covering 2025-12-24 to 2026-08-07. Get the full timeline:

Most recent: Clinical Trial Results: A First in Human Study of IBC-Ab002 in Persons With Early Alzheimer's Disease (AD) [Phase 1]